[Management of refractory neuroblastoma with high-dose topotecan plus cyclophosphamide and vincristine]

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Feb;16(2):120-3.
[Article in Chinese]
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child, Preschool
  • Cyclophosphamide / administration & dosage
  • Female
  • Humans
  • Male
  • Neuroblastoma / drug therapy*
  • Topotecan / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Topotecan
  • Cyclophosphamide